1. Singapore Stocks

  2. •

    Industrials

  3. •

    Conglomerates
Boustead Singapore Limited

Boustead Singapore Limited

F9D.SI
Boustead Singapore LimitedSG flagStock Exchange of Singapore
2.03
SGD
-0.04
- -
1.02BMarket Cap
Boustead Singapore Limited
F9D.SI
(Stock Exchange of Singapore)

Recent

price

2.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
1.11
0.81
1.02
1.01
1.08
0.94
0.83
0.74
0.95
1.48
1.41
1.31
1.17
1.61
1.09
1.25
1.09
Revenue per Share
0.1
0.11
0.16
0.14
0.12
0.05
0.06
0.05
0.07
0.06
0.23
0.06
0.09
0.13
0.2
0.47
0.05
Basic EPS, GAAP
0.08
0.16
0.08
0.2
0.08
0.14
0.12
0.07
0.01
0.28
0.12
0.11
0.15
0.19
0.14
-0.17
0.12
Free Cash Flow per Basic Share
0.06
0.07
0.05
0.04
0.05
0.02
0.03
0.03
0.03
0.02
0.03
0.09
0.04
0.04
0.03
0.04
0.02
Dividend per Share
0.5
0.54
0.65
0.74
0.8
0.66
0.66
0.69
0.7
0.74
0.95
0.93
1.03
1.15
1.29
1.69
0.71
Book Value per Share
0.46
0.52
0.61
0.7
0.75
0.79
0.85
0.85
0.97
1.01
1.37
1.31
1.18
1.1
1.22
1.63
0.97
Tangible Book Value per Share
506
506
503
509
516
520
522
520
493
490
486
483
480
477
486
499
491
Basic Weighted Avg Shares
561
409
513
514
556
487
434
385
471
727
686
632
562
768
527
624
537
Sales/Revenue/Turnover
13.23
13.63
15.1
15.5
14.31
11.46
11.47
13.76
10.7
9.07
9.42
5.34
8.48
12.12
18.99
12.04
7.81
Operating Margin (%)
4
4
5
8
8
11
11
10
10
17
17
12
10
11
9
9
13
Depreciation Expense
52
56
81
71
63
28
33
26
33
31
113
31
45
64
95
233
26
Net Income, GAAP
20.38
18.79
13.29
18.3
25.43
27.25
20.98
24.24
20.49
29.47
12.45
29.78
26.52
28.16
18.85
10.1
18.8
Effective Tax Rate (%)
9.32
13.6
15.85
13.76
11.37
5.8
7.67
6.84
6.91
4.25
16.49
4.84
8.07
8.36
18.03
37.25
4.81
Profit Margin (%)
213
159
232
200
299
267
273
288
252
233
404
401
192
193
166
294
233
Working Capital
22
18
25
47
174
88
70
65
80
117
58
64
44
32
28
25
119
LT Debt
237
264
312
362
390
410
447
443
482
497
666
633
571
529
596
816
478
Total Equity
20.97
16.14
21.91
17.68
12.29
7.7
7.81
7.88
7.19
7.07
7.89
3.32
5.24
10.89
13.13
8.64
5.64
Return on Invested Capital (%)
16.74
18.2
23.45
16.73
11.8
3.21
2.76
2.16
2.89
3.06
6.87
3.25
5.33
9.03
14.24
28.36
2.64
Return on Capital (%)
21.78
21.29
27.2
20.07
16.05
7.49
9.7
7.47
9.22
8.74
27.52
6.73
9.62
12.34
16.19
31.66
7.4
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'19
Jun'20
Sep'20
ST Debt
68
33
42
LT Borrowings
80
79
27
LT Finance Leases
- -
89
91
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
493
490
491
Market Capitalization
299
297
381

Working Capital

FRC

•

in mil. unless spec.
Mar'19
Jun'20
Sep'20
Total Current Assets
560
524
551
Cash, Cash Equivalents & STI
263
258
265
Accounts Receivable, Net
85
119
124
Inventories
4
5
4
Total Current Liabilities
308
287
318
Payables & Accruals
- -
- -
- -
ST Debt
68
33
42
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.16%
5.51%
37%
Free Cash Flow
139.69%
-38.79%
-223.48%
Net Income, GAAP
49.14%
41.94%
144.71%
Sales/Revenue/Turnover
5.37%
0.97%
18.47%
Total Cash Common Dividend
15.65%
26.24%
31.52%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
768
2025
- -
- -
- -
- -
527
2026
- -
- -
- -
- -
624

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.13
2025
- -
- -
- -
- -
0.2
2026
- -
- -
- -
- -
0.47

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.04
2025
- -
- -
- -
- -
0.03
2026
- -
- -
- -
- -
0.04
Similar Companies
Societe BIC S.A. (BICEF)
Sojitz Corporation (SZHFF)
Zuari Industries Limited (ZUARIIND.NS)
Hyosung Corporation (004800.KS)
Sojitz Corporation (2768.T)
Jaiprakash Associates Limited (JPASSOCIAT.BO)
Business
Boustead Singapore Limited, an investment holding enterprise, delivers advanced solutions in energy engineering, real estate, geospatial technology, and healthcare across various international markets, spanning Africa, Asia Pacific, Australia and Oceania, Europe, the Middle East, and North and South America. The company engineers, designs, and supplies sophisticated process heater systems, units for waste heat recovery, and associated equipment vital for the global oil and gas, petrochemical, and broader energy sectors. Furthermore, it conceptualizes, develops, and delivers emergency shutdown and process control mechanisms, including pneumatic and hydraulic, or safety programmable logic controller-based wellhead control panels and hydraulic power units, along with integrated control and safety shutdown systems, topside automation systems, chemical injection skids, fire and gas installations, and supervisory control and data acquisition systems for upstream oil and gas operations. It also provides water and wastewater treatment facilities for the oil and gas, petrochemical, pharmaceutical, power generation, semiconductor, and specialized defense industries, as well as for municipal entities. Additionally, the group designs, engineers, and provides compact power generation plants, facilities for solid waste energy recovery, and related combustion innovations. In its real estate segment, Boustead offers design-and-build expertise and development services for sustainable business parks and industrial complexes, having constructed extensive properties in Singapore, China, Malaysia, and Vietnam. This includes undertaking feasibility assessments, land acquisition, development planning, and financing, alongside providing asset and facilities management, with a recent focus on establishing a new logistics platform and exploring a REIT listing. The geospatial division provides comprehensive geographic information systems and location intelligence solutions, serving as the exclusive distributor of Esri's ArcGIS platform across key markets in Australia and Southeast Asia. Its healthcare technology arm focuses on the distribution of specialized medical solutions designed to address chronic conditions and mobility challenges prevalent with aging, emphasizing rehabilitative care, sleep science, and sports medicine within the Asia Pacific region. The company also engages in holding, managing, and leasing properties, and developing industrial spaces for rental or sale. Founded in 1828, the company maintains its headquarters in Singapore.